BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

SCYNEXIS, Inc. to Present on Screening Technology Used in Anti-Malarial Research at American Chemical Society National Meeting


8/20/2012 9:05:45 AM

RESEARCH TRIANGLE PARK, NC--(Marketwire - August 20, 2012) - SCYNEXIS, Inc. announces the presentation of innovative screening approaches used in the discovery of promising anti-malarial therapies at the American Chemical Society's (ACS) national meeting.

Paul J. Kowalczyk, Ph.D., senior computational chemist in the company's Integrated Parasitology division, will make the presentation titled, "Machine learning: Better practices applied to anti-malarial drug discovery." The presentation will be Wednesday Aug. 22, from 2:05-2:50 p.m. at the ACS' 244th National Meeting & Exposition in Philadelphia at the Pennsylvania Convention Center. The oral presentation is scheduled during the Perspective in Applied Computational Methods session.

With more than 164,000 members, the ACS is the world's largest scientific society and one of the world's leading sources of authoritative scientific information. A nonprofit organization, chartered by Congress, ACS is at the forefront of the evolving worldwide chemical enterprise and the premier professional home for chemists, chemical engineers and related professions around the globe.

SCYNEXIS' Kowalczyk will present sets of better practices for eight machine learning methods and the creation of a platform on which different compounds can be tested. It is the first truly reproducible research in the area of chemical informatics applied to drug discovery research, enabling the results to be easily verified. The SCYNEXIS platform also eliminates the need to share proprietary intellectual property while advancing potential treatments for so-called neglected diseases like malaria by testing multiple compounds against the same platform.

SCYNEXIS has been involved for years in joint research for screening potential treatments for neglected diseases such as malaria and sleeping sickness.

The company has also developed a robust screening platform for the assessment of compounds against parasite species relevant to neglected tropical diseases. The platform was designed to identify compounds with potential activity in the areas of human and public health.

About SCYNEXIS, Inc.
SCYNEXIS delivers innovative solutions to solve the toughest problems in drug discovery and development for our pharmaceutical, global health and life science partners. We have successfully delivered preclinical and clinical drug candidates to our customers across all major therapeutic indications and have developed a proprietary cyclophilin inhibitor pipeline for the treatment of a broad range of diseases, including HCV and inflammation. www.scynexis.com.


For further information, please contact:

SCYNEXIS Media Contacts:
Rick Rountree
Rick Rountree Communications, Inc.
rick@rickrountree.com
Tel. +1 919-878-1144

Alissa Maupin
SCYNEXIS
Marketing & Communications Manager
alissa.maupin@scynexis.com
Tel. +1 919-206-7246



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES